Open Access
Med Sci (Paris)
Volume 37, Number 12, Décembre 2021
Vésicules extracellulaires
Page(s) 1146 - 1157
Section Vésicules extracellulaires
Published online 20 December 2021
  1. Verma M, Lam TK, Hebert E, et al. Extracellular vesicles: potential applications in cancer diagnosis, prognosis, and epidemiology. BMC Clin Pathol 2015 ; 15 : [CrossRef] [PubMed] [Google Scholar]
  2. Saint-Pol J, Gosselet F, Duban-Deweer S, et al. Targeting and Crossing the Blood-Brain Barrier with Extracellular Vesicles. Cells 2020; 9 : 851. [CrossRef] [Google Scholar]
  3. Wiklander OPB, Brennan MÁ, Lötvall J, et al. Advances in therapeutic applications of extracellular vesicles. Sci Transl Med 2019; 11 : eaav8521. [CrossRef] [PubMed] [Google Scholar]
  4. Nagelkerke A, Ojansivu M, Koog L van der, et al. Extracellular vesicles for tissue repair and regeneration: evidence, challenges and opportunities. Adv Drug Deliv Rev 2021; 175 : 113775. [CrossRef] [PubMed] [Google Scholar]
  5. Elsharkasy OM, Nordin JZ, Hagey DW, et al. Extracellular vesicles as drug delivery systems: Why and how? Adv Drug Deliv Rev 2020; 159 : 332–43. [CrossRef] [PubMed] [Google Scholar]
  6. Lener T, Gimona M, Aigner L, et al. Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper. J Extracell Vesicles 2015; 4. [Google Scholar]
  7. Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 2018 ; 7 : 1535750. [CrossRef] [PubMed] [Google Scholar]
  8. Rohban R, Pieber TRMesenchymal Stem and Progenitor Cells in Regeneration: Tissue Specificity and Regenerative Potential. Stem Cells Int 2017 ; 2017 : e5173732. [CrossRef] [Google Scholar]
  9. Grangier A, Branchu J, Volatron J, et al. Technological advances towards extracellular vesicles mass production. Adv Drug Deliv Rev 2021; 113843. [CrossRef] [PubMed] [Google Scholar]
  10. Piffoux M, Nicolás-Boluda A, Mulens-Arias V, et al. Extracellular vesicles for personalized medicine: The input of physically triggered production, loading and theranostic properties. Adv Drug Deliv Rev 2019 ; 138 : 247–258. [CrossRef] [PubMed] [Google Scholar]
  11. Anne-Clémence Vion, Bhama Ramkhelawon, Xavier Loyer, et al. Shear Stress Regulates Endothelial Microparticle Release. Circul Res 2013 ; 112 : 1323–1333. [CrossRef] [PubMed] [Google Scholar]
  12. Pinto A, Marangon I, Méreaux J, et al. Immune Reprogramming Precision Photodynamic Therapy of Peritoneal Metastasis by Scalable Stem-Cell-Derived Extracellular Vesicles. ACS Nano 2021; 15 : 3251–63. [CrossRef] [PubMed] [Google Scholar]
  13. Berger A, Araújo-Filho I, Piffoux M, et al. Local administration of stem cell-derived extracellular vesicles in a thermoresponsive hydrogel promotes a pro-healing effect in a rat model of colo-cutaneous post-surgical fistula. Nanoscale 2021; 13 : 218–32. [CrossRef] [PubMed] [Google Scholar]
  14. Aubertin K, Silva AKA, Luciani N, et al. Massive release of extracellular vesicles from cancer cells after photodynamic treatment or chemotherapy. Sci Rep 2016 ; 6 : 35376. [CrossRef] [PubMed] [Google Scholar]
  15. Keklikoglou I, Cianciaruso C, Güç E, et al. Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models. Nat Cell Biol 2019 ; 21 : 190–202. [CrossRef] [PubMed] [Google Scholar]
  16. Gauthier NC, Fardin MA, Roca-Cusachs P, et al. Temporary increase in plasma membrane tension coordinates the activation of exocytosis and contraction during cell spreading. Proc Natl Acad Sci U S A 2011 ; 108 : 14467–14472. [CrossRef] [PubMed] [Google Scholar]
  17. Bodin P, Burnstock GEvidence That Release of Adenosine Triphosphate From Endothelial Cells During Increased Shear Stress Is Vesicular. J Cardiovasc Pharmacol 2001 ; 38 : 900–908. [CrossRef] [PubMed] [Google Scholar]
  18. de Jong OG, Verhaar MC, Chen Y, et al. Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes. J Extracell Vesicles 2012 ; 1 : 18396. [CrossRef] [Google Scholar]
  19. Park K-S, Bandeira E, Shelke GV, et al. Enhancement of therapeutic potential of mesenchymal stem cell-derived extracellular vesicles. Stem Cell Res Ther 2019 ; 10 : 288. [CrossRef] [PubMed] [Google Scholar]
  20. Staubach S, Bauer FN, Tertel T, et al. Scaled preparation of extracellular vesicles from conditioned media. Adv Drug Deliv Rev 2021; 177 : 113940. [CrossRef] [PubMed] [Google Scholar]
  21. Gupta D, Maria Zickler A, EL Andaloussi S. Dosing Extracellular Vesicles. Adv Drug Deliv Rev 2021; 113961. [CrossRef] [PubMed] [Google Scholar]
  22. Bonsergent E, Grisard E, Buchrieser J, et al. Quantitative characterization of extracellular vesicle uptake and content delivery within mammalian cells. Nat Commun 2021; 12 : 1864. [CrossRef] [PubMed] [Google Scholar]
  23. van Balkom BWM, Gremmels H, Giebel B, et al. Proteomic Signature of Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles. Proteomics 2019 ; 19 : 1800163. [CrossRef] [Google Scholar]
  24. Sebbagh AC, Rosenbaum B, Péré G, et al. Regenerative medicine for digestive fistulae therapy: benefits, challenges and promises of stem/stromal cells and emergent perspectives via their extracellular vesicles. Adv Drug Deliv Rev 2021; 113841. [CrossRef] [PubMed] [Google Scholar]
  25. Maumus M, Pers Y-M, Ruiz M, et al. Cellules souches mésenchymateuses et médecine régénératrice - Quel avenir pour l’arthrose ?. Med Sci (Paris) 2018 ; 34 : 1092–1099. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  26. Kordelas L, Rebmann V, Ludwig A-K, et al. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia 2014 ; 28 : 970–973. [CrossRef] [PubMed] [Google Scholar]
  27. Doeppner TR, Herz J, Görgens A, et al. Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression. Stem Cells Transl Med 2015 ; 4 : 1131–1143. [CrossRef] [PubMed] [Google Scholar]
  28. Liao Z, Liu H, Ma L, et al. Engineering Extracellular Vesicles Restore the Impaired Cellular Uptake and Attenuate Intervertebral Disc Degeneration. ACS Nano 2021; 15(9) : 14709–24. [CrossRef] [PubMed] [Google Scholar]
  29. Lai RC, Arslan F, Lee MM, et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 2010 ; 4 : 214–222. [CrossRef] [PubMed] [Google Scholar]
  30. Clement O, Cellier C, Wilhelm C, et al. Compositions useful for mucosal healing. WO/2018/011192. [Google Scholar]
  31. Silva AKA, Perretta S, Perrod G, et al. Thermoresponsive Gel Embedded with Adipose Stem-Cell-Derived Extracellular Vesicles Promotes Esophageal Fistula Healing in a Thermo-Actuated Delivery Strategy. ACS Nano 2018 ; 12 : 9800–9814. [CrossRef] [PubMed] [Google Scholar]
  32. Berger A, Caudron E, Perrod G, et al. Enhancing digestive fistula healing by the off-label use of a thermoresponsive vessel occluder polymer associated with esophageal stent placement: A case report. Clin Res Hepatol Gastroenterol 2021; 45 : 101474. [CrossRef] [PubMed] [Google Scholar]
  33. Coffin E, Grangier A, Perrod G, et al. Extracellular vesicles from adipose stromal cells combined with a thermoresponsive hydrogel prevent esophageal stricture after extensive endoscopic submucosal dissection in a porcine model. Nanoscale 2021; 13 : 14866–78. [CrossRef] [PubMed] [Google Scholar]
  34. Kervadec A, Bellamy V, El Harane N, et al. Cardiovascular progenitor-derived extracellular vesicles recapitulate the beneficial effects of their parent cells in the treatment of chronic heart failure. J Heart Lung Transplant 2016 ; 35 : 795–807. [Google Scholar]
  35. Gao L, Wang L, Wei Y, et al. Exosomes secreted by hiPSC-derived cardiac cells improve recovery from myocardial infarction in swine. Sci Transl Med 2020; 12 : eaay1318. [CrossRef] [PubMed] [Google Scholar]
  36. El Harane N, Kervadec A, Bellamy V, et al. Acellular therapeutic approach for heart failure: in vitro production of extracellular vesicles from human cardiovascular progenitors. Eur Heart J 2018 ; 39 : 1835–1847. [CrossRef] [PubMed] [Google Scholar]
  37. Lima Correa B, El Harane N, Gomez I, et al. Extracellular vesicles from human cardiovascular progenitors trigger a reparative immune response in infarcted hearts. Cardiovascul Res 2021; 117 : 292–307. [CrossRef] [PubMed] [Google Scholar]
  38. Cosenza S, Ruiz M, Toupet K, et al. Mesenchymal stem cells derived exosomes and microparticles protect cartilage and bone from degradation in osteoarthritis. Sci Rep 2017 ; 7 : 16214. [CrossRef] [PubMed] [Google Scholar]
  39. Cosenza S, Toupet K, Maumus M, et al. Mesenchymal stem cells-derived exosomes are more immunosuppressive than microparticles in inflammatory arthritis. Theranostics 2018 ; 8 : 1399–1410. [CrossRef] [PubMed] [Google Scholar]
  40. Rozier P, Maumus M, Maria ATJ, et al. Mesenchymal stromal cells-derived extracellular vesicles alleviate systemic sclerosis via miR-29a-3p. J Autoimmun 2021; 121 : 102660. [CrossRef] [PubMed] [Google Scholar]
  41. Warnecke A, Prenzler N, Harre J, et al. First-in-human intracochlear application of human stromal cell-derived extracellular vesicles. J Extracell Vesicles 2021; 10 : e12094. [CrossRef] [PubMed] [Google Scholar]
  42. Warnecke A, Harre J, Staecker H, et al. Extracellular vesicles from human multipotent stromal cells protect against hearing loss after noise trauma in vivo. Clin Transl Med 2020; 10 : e262. [CrossRef] [PubMed] [Google Scholar]
  43. Piffoux M, Volatron J, Cherukula K, et al. Engineering and loading therapeutic extracellular vesicles for clinical translation: a data reporting frame for comparability. Adv Drug Deliv Rev 2021; 113972. [CrossRef] [PubMed] [Google Scholar]
  44. Piffoux M, Silva AKA, Wilhelm C, et al. Modification of Extracellular Vesicles by Fusion with Liposomes for the Design of Personalized Biogenic Drug Delivery Systems. ACS Nano 2018 ; 12 : 6830–6842. [CrossRef] [PubMed] [Google Scholar]
  45. Toledano Furman NE, Lupu-Haber Y, Bronshtein T, et al. Reconstructed Stem Cell Nanoghosts: A Natural Tumor Targeting Platform. Nano Lett 2013 ; 13 : 3248–3255. [CrossRef] [PubMed] [Google Scholar]
  46. Silva AKA, Kolosnjaj-Tabi J, Bonneau S, et al. Magnetic and Photoresponsive Theranosomes: Translating Cell-Released Vesicles into Smart Nanovectors for Cancer Therapy. ACS Nano 2013 ; 7 : 4954–4966. [CrossRef] [PubMed] [Google Scholar]
  47. Yakavets I, Francois A, Lamy L, et al. Effect of stroma on the behavior of temoporfin-loaded lipid nanovesicles inside the stroma-rich head and neck carcinoma spheroids. J Nanobiotech 2021; 19 : 3. [CrossRef] [Google Scholar]
  48. Jang SC, Economides KD, Moniz RJ, et al. ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance. Commun Biol 2021; 4 : 1–17. [CrossRef] [PubMed] [Google Scholar]
  49. Chanut R, Petrilli VDétection de l’ADN cytosolique par la voie cGAS-STING - De l’immunité innée vers le contrôle de la tumorigenèse. Med Sci (Paris) 2019 ; 35 : 527–534. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  50. Camargo LCB de, Guaddachi F, Bergerat D, et al. Extracellular vesicles produced by NFAT3-expressing cells hinder tumor growth and metastatic dissemination. Sci Rep 2020; 10 : 8964. [CrossRef] [PubMed] [Google Scholar]
  51. Perets N, Oron O, Herman S, et al. Exosomes derived from mesenchymal stem cells improved core symptoms of genetically modified mouse model of autism Shank3B. Molecular Autism 2020; 11 : 65. [CrossRef] [PubMed] [Google Scholar]
  52. Seras-Franzoso J, Díaz-Riascos ZV, Corchero JL, et al. Extracellular vesicles from recombinant cell factories improve the activity and efficacy of enzymes defective in lysosomal storage disorders. J Extracell Vesicles 2021; 10 : e12058. [CrossRef] [PubMed] [Google Scholar]
  53. Silva AKA, Morille M, Piffoux M, et al. Development of extracellular vesicle-based medicinal products: a position paper of the group Extracellular Vesicle translatiOn to clinicaL perspectiVEs - EVOLVE France. Adv Drug Deliv Rev 2021; 179 : 114001. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.